Keay Nakae
Stock Analyst at Chardan Capital
(3.47)
# 2,290
Out of 4,517 analysts
601
Total ratings
39.5%
Success rate
3.1%
Average return
Main Sectors:
Stocks Rated by Keay Nakae
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EPA: SIGHT GenSight Biologics S.A. | Maintained: Hold | €0.08 | €0.08 | -0.87% | 3 | Jul 15, 2026 | |
| IBIO iBio, Inc. | Reiterated: Buy | $5 | $1.35 | +270.37% | 7 | Jul 1, 2026 | |
| ARWR Arrowhead Pharmaceuticals | Maintained: Buy | $90 | $71.38 | +26.09% | 47 | Jun 29, 2026 | |
| PRQR ProQR Therapeutics | Reiterated: Buy | $4 → $3 | $1.67 | +79.64% | 40 | Jun 25, 2026 | |
| SABS SAB Biotherapeutics | Reiterated: Buy | $14 → $16 | $3.67 | +336.56% | 20 | Jun 16, 2026 | |
| BME: PHM Pharma Mar, S.A. | Maintained: Buy | €120.00 → €100.00 | €76.00 | +31.58% | 8 | Jun 14, 2026 | |
| CAMP Camp4 Therapeutics | Initiated Coverage: Buy | $6.5 | $3.90 | +66.67% | 1 | Jun 10, 2026 | |
| COYA Coya Therapeutics | Maintained: Buy | $14 | $4.60 | +204.35% | 19 | May 12, 2026 | |
| DYN Dyne Therapeutics | Maintained: Buy | $38 | $22.72 | +67.25% | 17 | May 11, 2026 | |
| KRRO Korro Bio | Reiterated: Buy | $15 | $12.28 | +22.15% | 5 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $35 → $27 | $10.92 | +147.25% | 17 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $425 | $283.15 | +50.10% | 51 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $30 | $27.33 | +9.77% | 4 | Apr 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | ¥800 | ¥267 | +199.63% | 1 | Apr 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 | $3.72 | +437.63% | 12 | Mar 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $2.5 → $45 | $5.00 | +800.00% | 6 | Feb 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 | $0.551 | +7,159.53% | 1 | Jan 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $35 | $29.11 | +20.23% | 1 | Jan 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €10.00 → €5.00 | €0.62 | +709.06% | 5 | Sep 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $60 → $85 | $108.52 | -21.67% | 2 | Sep 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $25 → $6 | $5.18 | n/a | 19 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $11.42 | n/a | 1 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.00001 | n/a | 4 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.70115 | n/a | 20 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.47 | n/a | 1 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $12 | $0.89 | n/a | 1 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4.5 → $5 | $4.74 | n/a | 47 | Nov 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $1.66 | n/a | 7 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 → $8 | $3.05 | n/a | 14 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0001 | n/a | 13 | Mar 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $17.86 | n/a | 16 | Dec 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $15.21 | n/a | 1 | Mar 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $7.69 | n/a | 31 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $8.24 | n/a | 5 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $44.99 | n/a | 6 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.207 | n/a | 18 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $9.40 | n/a | 1 | Feb 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $100 → $50 | $0.0001 | n/a | 8 | Nov 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.62 | n/a | 15 | Sep 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.17 | n/a | 15 | Jul 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $3.50 | n/a | 8 | Jul 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2,099.00 | n/a | 9 | Jul 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $6.18 | n/a | 9 | Jul 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.000001 | n/a | 6 | Jul 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $8.81 | n/a | 5 | Jul 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $8 → $4.5 | $1.37 | n/a | 9 | Jun 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.742 | n/a | 2 | Nov 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $2 | $4.71 | n/a | 11 | Jul 30, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $63.15 | n/a | 1 | Mar 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0001 | n/a | 2 | Jan 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $18.03 | n/a | 3 | Jun 10, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $11.50 | n/a | 1 | Jun 10, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3.3 → $4.5 | $0.88 | n/a | 3 | Feb 16, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6 | $2.55 | n/a | 3 | Dec 6, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 | $1.00 | n/a | 1 | Aug 23, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $2.25 | $2.33 | n/a | 1 | Aug 12, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $2.25 → $2 | $0.0001 | n/a | 4 | Jul 8, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 → $6 | $1.79 | n/a | 4 | Mar 28, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $16 | $1.72 | n/a | 1 | Dec 3, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $4 | $3.90 | n/a | 1 | Aug 6, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $100 → $18 | $0.0002 | n/a | 3 | May 15, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $13 | $4.23 | n/a | 1 | Oct 7, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5.5 | $0.0001 | n/a | 1 | Jul 3, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $2.3 | $0.2284 | n/a | 1 | Jun 25, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $47.81 | n/a | 1 | May 16, 2012 |
GenSight Biologics S.A.
Jul 15, 2026
Maintained: Hold
Price Target: €0.08
Current: €0.08
Upside: -0.87%
iBio, Inc.
Jul 1, 2026
Reiterated: Buy
Price Target: $5
Current: $1.35
Upside: +270.37%
Arrowhead Pharmaceuticals
Jun 29, 2026
Maintained: Buy
Price Target: $90
Current: $71.38
Upside: +26.09%
ProQR Therapeutics
Jun 25, 2026
Reiterated: Buy
Price Target: $4 → $3
Current: $1.67
Upside: +79.64%
SAB Biotherapeutics
Jun 16, 2026
Reiterated: Buy
Price Target: $14 → $16
Current: $3.67
Upside: +336.56%
Pharma Mar, S.A.
Jun 14, 2026
Maintained: Buy
Price Target: €120.00 → €100.00
Current: €76.00
Upside: +31.58%
Camp4 Therapeutics
Jun 10, 2026
Initiated Coverage: Buy
Price Target: $6.5
Current: $3.90
Upside: +66.67%
Coya Therapeutics
May 12, 2026
Maintained: Buy
Price Target: $14
Current: $4.60
Upside: +204.35%
Dyne Therapeutics
May 11, 2026
Maintained: Buy
Price Target: $38
Current: $22.72
Upside: +67.25%
Korro Bio
May 7, 2026
Reiterated: Buy
Price Target: $15
Current: $12.28
Upside: +22.15%
May 7, 2026
Maintained: Buy
Price Target: $35 → $27
Current: $10.92
Upside: +147.25%
May 1, 2026
Reiterated: Buy
Price Target: $425
Current: $283.15
Upside: +50.10%
Apr 21, 2026
Maintained: Buy
Price Target: $30
Current: $27.33
Upside: +9.77%
Apr 7, 2026
Initiated Coverage: Buy
Price Target: ¥800
Current: ¥267
Upside: +199.63%
Mar 12, 2026
Maintained: Buy
Price Target: $20
Current: $3.72
Upside: +437.63%
Feb 24, 2026
Upgraded: Buy
Price Target: $2.5 → $45
Current: $5.00
Upside: +800.00%
Jan 5, 2026
Maintained: Buy
Price Target: $40
Current: $0.551
Upside: +7,159.53%
Jan 5, 2026
Maintained: Buy
Price Target: $35
Current: $29.11
Upside: +20.23%
Sep 30, 2025
Maintained: Buy
Price Target: €10.00 → €5.00
Current: €0.62
Upside: +709.06%
Sep 25, 2025
Maintained: Buy
Price Target: $60 → $85
Current: $108.52
Upside: -21.67%
May 8, 2025
Downgraded: Hold
Price Target: $25 → $6
Current: $5.18
Upside: n/a
Dec 20, 2024
Rated: Hold
Price Target: n/a
Current: $11.42
Upside: n/a
Dec 20, 2024
Rated: Hold
Price Target: n/a
Current: $0.00001
Upside: n/a
Dec 20, 2024
Rated: Hold
Price Target: n/a
Current: $0.70115
Upside: n/a
Dec 20, 2024
Rated: Hold
Price Target: n/a
Current: $1.47
Upside: n/a
Dec 20, 2024
Maintained: Hold
Price Target: $12
Current: $0.89
Upside: n/a
Nov 19, 2024
Maintained: Buy
Price Target: $4.5 → $5
Current: $4.74
Upside: n/a
Nov 18, 2024
Reiterated: Buy
Price Target: $6
Current: $1.66
Upside: n/a
Nov 12, 2024
Maintained: Buy
Price Target: $10 → $8
Current: $3.05
Upside: n/a
Mar 14, 2024
Rated: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Dec 12, 2023
Rated: Hold
Price Target: n/a
Current: $17.86
Upside: n/a
Mar 9, 2023
Reiterated: Buy
Price Target: n/a
Current: $15.21
Upside: n/a
Feb 17, 2023
Rated: Hold
Price Target: n/a
Current: $7.69
Upside: n/a
Feb 17, 2023
Rated: Hold
Price Target: n/a
Current: $8.24
Upside: n/a
Feb 17, 2023
Rated: Hold
Price Target: n/a
Current: $44.99
Upside: n/a
Feb 17, 2023
Rated: Hold
Price Target: n/a
Current: $0.207
Upside: n/a
Feb 6, 2023
Reiterated: Buy
Price Target: n/a
Current: $9.40
Upside: n/a
Nov 16, 2022
Downgraded: Hold
Price Target: $100 → $50
Current: $0.0001
Upside: n/a
Sep 30, 2022
Rated: Hold
Price Target: n/a
Current: $1.62
Upside: n/a
Jul 30, 2021
Rated: Hold
Price Target: n/a
Current: $1.17
Upside: n/a
Jul 30, 2021
Rated: Hold
Price Target: n/a
Current: $3.50
Upside: n/a
Jul 30, 2021
Rated: Hold
Price Target: n/a
Current: $2,099.00
Upside: n/a
Jul 30, 2021
Rated: Hold
Price Target: n/a
Current: $6.18
Upside: n/a
Jul 30, 2021
Rated: Hold
Price Target: n/a
Current: $0.000001
Upside: n/a
Jul 30, 2021
Rated: Hold
Price Target: n/a
Current: $8.81
Upside: n/a
Jun 10, 2021
Reiterated: Hold
Price Target: $8 → $4.5
Current: $1.37
Upside: n/a
Nov 20, 2020
Rated: Hold
Price Target: n/a
Current: $0.742
Upside: n/a
Jul 30, 2020
Rated: Hold
Price Target: $2
Current: $4.71
Upside: n/a
Mar 23, 2020
Reiterated: Buy
Price Target: n/a
Current: $63.15
Upside: n/a
Jan 28, 2020
Rated: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Jun 10, 2019
Rated: Hold
Price Target: n/a
Current: $18.03
Upside: n/a
Jun 10, 2019
Rated: Hold
Price Target: n/a
Current: $11.50
Upside: n/a
Feb 16, 2017
Maintained: Buy
Price Target: $3.3 → $4.5
Current: $0.88
Upside: n/a
Dec 6, 2016
Maintained: Buy
Price Target: $6
Current: $2.55
Upside: n/a
Aug 23, 2016
Maintained: Buy
Price Target: $4
Current: $1.00
Upside: n/a
Aug 12, 2016
Reiterated: Buy
Price Target: $2.25
Current: $2.33
Upside: n/a
Jul 8, 2016
Maintained: Buy
Price Target: $2.25 → $2
Current: $0.0001
Upside: n/a
Mar 28, 2016
Reiterated: Buy
Price Target: $12 → $6
Current: $1.79
Upside: n/a
Dec 3, 2014
Initiated Coverage: Buy
Price Target: $16
Current: $1.72
Upside: n/a
Aug 6, 2014
Downgraded: Hold
Price Target: $4
Current: $3.90
Upside: n/a
May 15, 2014
Downgraded: Hold
Price Target: $100 → $18
Current: $0.0002
Upside: n/a
Oct 7, 2013
Initiated Coverage: Buy
Price Target: $13
Current: $4.23
Upside: n/a
Jul 3, 2013
Reiterated: Buy
Price Target: $5.5
Current: $0.0001
Upside: n/a
Jun 25, 2013
Initiated Coverage: Buy
Price Target: $2.3
Current: $0.2284
Upside: n/a
May 16, 2012
Initiated Coverage: Buy
Price Target: n/a
Current: $47.81
Upside: n/a